GURUFOCUS.COM » STOCK LIST » Asia » Hong Kong » HKSE » China Medical & HealthCare Group Ltd (HKSE:00383) » Definitions » 3-Year ROIIC %
Switch to:

China Medical & HealthCare Group (HKSE:00383) 3-Year ROIIC %

: 15.89% (As of Dec. 2021)
View and export this data going back to 1991. Start your Free Trial

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. China Medical & HealthCare Group does not have enough data to calculate 3-Year ROIIC %.

Competitive Comparison

For the Medical Care Facilities subindustry, China Medical & HealthCare Group's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical & HealthCare Group 3-Year ROIIC % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, China Medical & HealthCare Group's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where China Medical & HealthCare Group's 3-Year ROIIC % falls in comparison to its industry or sector. The grey bar indicates the 3-Year ROIIC %'s extreme value range as defined by GuruFocus.

China Medical & HealthCare Group 3-Year ROIIC % Calculation

China Medical & HealthCare Group's 3-Year ROIIC % for the quarter that ended in Dec. 2021 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 40.7543854 (Dec. 2021) - (Dec. 2018) )/( 3197.184 (Dec. 2021) - (Dec. 2018) )
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

**Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.

China Medical & HealthCare Group  (HKSE:00383) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

China Medical & HealthCare Group 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of China Medical & HealthCare Group's 3-Year ROIIC % provided by Please click on the following links to see related term pages.

China Medical & HealthCare Group (HKSE:00383) Business Description

China Medical & HealthCare Group logo
Traded in Other Exchanges
333 Lockhart Road, 47th Floor, China Online Centre, Wanchai, Hong Kong, HKG
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from Healthcare segment that is engaged in operations of hospitals in the PRC.

China Medical & HealthCare Group (HKSE:00383) Headlines

No Headlines